Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pohl

Showing results (161-170 of 189) with videos related to

Pageof 19
Sort By:
Neurology|November 30, 2006
Blockade of chemokine signaling in patients with multiple sclerosisF Zipp, H P Hartung, J Hillert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2008
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosisI J van den Elskamp, J Lembcke, V Dattola, et al.
Veterinary Immunology and Immunopathology|September 26, 2006
Vaccination of bovines with recombinant Boophilus Yolk pro-CathepsinAlexandre T Leal, Adriana Seixas, Paula C Pohl, et al.
Neurology|August 18, 2006
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesL Kappos, C H Polman, M S Freedman, et al.
Cold Spring Harbor Symposia on Quantitative Biology|September 2, 2004
Mutational profiling in the human genomeR K Wilson, T J Ley, F S Cole, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFITG Edan, L Kappos, X Montalbán, et al.
Veterinary Parasitology|December 4, 2012
Chemical composition and efficacy of dichloromethane extract of Croton sphaerogynus Baill. (Euphorbiaceae) against the cattle tick Rhipicephalus microplus (Acari: Ixodidae)Adne A Righi, Lucimar B Motta, Guilherme M Klafke, et al.
Acta Neuropathologica|January 24, 2024
Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomasLara C Pohl, Maximilian Leitheiser, Denise Obrecht, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2007
Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging resultsJ M Nielsen, B Moraal, C H Polman, et al.
Neuroradiology|January 6, 2010
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosisI J van den Elskamp, B Boden, V Dattola, et al.
Pageof 19

Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Neurology|November 30, 2006
Blockade of chemokine signaling in patients with multiple sclerosisF Zipp, H P Hartung, J Hillert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2008
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosisI J van den Elskamp, J Lembcke, V Dattola, et al.
Veterinary Immunology and Immunopathology|September 26, 2006
Vaccination of bovines with recombinant Boophilus Yolk pro-CathepsinAlexandre T Leal, Adriana Seixas, Paula C Pohl, et al.
Neurology|August 18, 2006
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesL Kappos, C H Polman, M S Freedman, et al.
Cold Spring Harbor Symposia on Quantitative Biology|September 2, 2004
Mutational profiling in the human genomeR K Wilson, T J Ley, F S Cole, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFITG Edan, L Kappos, X Montalbán, et al.
Veterinary Parasitology|December 4, 2012
Chemical composition and efficacy of dichloromethane extract of Croton sphaerogynus Baill. (Euphorbiaceae) against the cattle tick Rhipicephalus microplus (Acari: Ixodidae)Adne A Righi, Lucimar B Motta, Guilherme M Klafke, et al.
Acta Neuropathologica|January 24, 2024
Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomasLara C Pohl, Maximilian Leitheiser, Denise Obrecht, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2007
Classification of patients with a clinically isolated syndrome based on signs and symptoms is supported by magnetic resonance imaging resultsJ M Nielsen, B Moraal, C H Polman, et al.
Neuroradiology|January 6, 2010
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosisI J van den Elskamp, B Boden, V Dattola, et al.
Pageof 19